A network paradigm predicts drug synergistic effects using downstream protein–protein interactions
Abstract In some cases, drug combinations affect adverse outcome phenotypes by binding the same protein; however, drug‐binding proteins are associated through protein–protein interaction (PPI) networks within the cell, suggesting that drug phenotypes may result from long‐range network effects. We fi...
Main Authors: | Jennifer L. Wilson, Ethan Steinberg, Rebecca Racz, Russ B. Altman, Nigam Shah, Kevin Grimes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-11-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12861 |
Similar Items
-
Downstream processing of proteins /
by: 307725 Becker, Todd, et al. -
Databases of ligand-binding pockets and protein-ligand interactions
by: Kristy A. Carpenter, et al.
Published: (2024-12-01) -
Trends in downstream processing of proteins and enzymes /
by: 307981 Dunhill, P. -
Glycomics : an emerging paradigm to protein-carbohydrate interactions
by: Raman, Rahul, 1977-
Published: (2006) -
Glycosaminoglycan-protein interactions : the fibroblast growth factor paradigm
by: Kwan, Chi-Pong, 1973-
Published: (2005)